亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。
suramab, a new pharmaceutical compound with antiangiogenic effects
總結
This can be seen in the patent file
技術優勢
Suramab is the brand name of a new combination of drugs made up of suramin and bevacizumab. Suramab has antiangiogenic properties that can be applied to oncological and ophthalmological diseases.
The european patent (EP 2186529 B1) was granted in March 2012.
The US patent is still pending
申請號碼
MX2008000104
覆蓋範圍
Great Britain, Ireland, Sweden, Denmark, The Netherland, Germany, Spain, France
商品和服務
License agreement
專利信息
Issued patent
國家/地區
阿根廷
欲了解更多信息，請點擊 這裡
